Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
To characterize the GORE® Hybrid Vascular Graft as compared to non-heparin bonded synthetic vascular grafts in terms of the prevalence and persistence of anti-platelet factor 4 / heparin antibodies (anti-PF4 / H antibodies).
Epistemonikos ID: 5b0cb524d90809367cedf2682424f9a2913ffe28
First added on: May 11, 2024